The global pandemic has clearly emphasized how closely related biomedical research and patients’ health are, bringing out new clinical and methodological challenges and highlighting weaknesses of several research methods.
The conference program has been built to point out the need for a sustainable ecosystem of evidence, trying to give clear answers to the future challenges that should be addressed to connect the generation, synthesis and translation of evidence to individuals and populations.
Worldwide EBHC leaders will trace this way, and dozens of researchers will present their experiences departing from two main topics: the lessons learned in the pandemic era to produce, synthesize and apply updated evidence for global health and the need for an EBP core curriculum for all health professionals.
Conference inauguration (18.30 – 20.00)
More than 30 years ago the Evidence-Based Medicine Working Group announced a “new paradigm” for teaching and practicing healthcare.
Three decades of enthusiasm have produced numerous successes for Evidence-Based Practice, but wide variation in implementing EBP remains a problem. Less than ten years ago, the Evidence-Based Medicine Renaissance Group traced a preliminary agenda to fight the EBM crisis, but how has the global pandemic affected the way for the renaissance? EBHC leaders will help us to take a look at the future of evidence-based teaching, education, research and practice.
KEYNOTE | EBM 32 years later: achieved goals and unresolved issues
Gordon Guyatt | McMaster University, Canada
EBM’s triumphs: incorporation as a mandatory component of undergraduate and postgraduate health sciences training training; universal recognition as a core element of medical practice. EBM’s failures: Educators failure to focus on understanding evidence summaries rather than critical appraisal. The evidence processing leadership has failed to appropriately balance simplicity (undervalued) with methodological sophistication (overvalued).
KEYNOTE | Looking into the future: evidence-based education, research and practice
Paul Glasziou | Bond University, Australia
Looking into the future: evidence-based education, research and practice
Since the term EBM was coined in the 1990's, the evidence ecosystem has seen numerous changes: a vast increase in systematic reviews, the advent of GRADE, and most recently the rise of AI. Some have called for abandoning or revolutionizing EBM. However, while some evolution is clearly needed the key principles remain, akin to Copernican heliocentrism. Some principles for the evolution are:
1. Teach the fundamentals of EBM: skepticism, probabilistic thinking, and rules of evidence
2. Improve methods and skills in evidence navigation
3. Support patients decision making: practice and teach Shared Decision Making alongside EBM
4. Beware diagnosis creep: our definitions are more important than our tests
5. Take non-drug interventions as seriously as pharmaceuticals
6. Support clinical practice networks for research and evidence translation
7. Improve our evidence infrastructure: automation of evidence synthesis and meta-research
The talk will explain why and how each of these might be achieved.
Plenary session 1 (08.30 – 10.45)
CHAIR - Gordon Guyatt
The global pandemic has clearly emphasized the demand for evidence that must be urgently processed, synthesized and translated into clinical recommendations. New research methods have been implemented, while old ones have been updated and optimized to satisfy the need for further evidence to be produced in response to emerging healthcare needs. Starting from the “covidization” of medical science, EBP leaders will show how to engage citizen partners to build a real Evidence-Based translational medicine.
KEYNOTE | The covidization of medical science
John Ioannidis | Stanford University, USA
The COVID-19 pandemic left a footprint on the research and scientific literature landscape. The validity, transparency and reproducibility of this literature has faced major deficiencies and challenges. COVID-19 science showed rapid turn-around and multiple refutations. Insights have accumulated during the pandemic pertaining to changes in production of evidence, timing of evidence, replication cycling, and peer-review.
KEYNOTE | Evidence-based translational medicine: connecting basic and clinical research
Emily Sena | University of Edinburgh, United Kingdom
Discrepancies between the results of preclinical animal studies and human clinical trials, and limited reproducibility between laboratories, has in part been attributed to compromised internal and external validity of animal experiments, and the presence of publication bias. Improving our approach to preclinical practice and evidence based clinical trial design may improve translation from bench to bedside.
Living evidence to inform health decisions framework (LE-IHD): a practical interactive framework based tool to guide the incorporation of Living Evidence in the development of knowledge transfer products
Maria Ximena Rojas | Institut d'Recerca Hospital de la Santa Creu i Sant Pau, Spain
Effectiveness and user experience of digital plain language COVID-19 health recommendations (PLR) in people of different age and health literacy: Results of three randomized controlled trials and qualitative studies
Holger Schunemann | McMaster University, Canada
Dead on arrival? An overview of living systematic reviews and their methodological rigor
Melanie Golob | University of Oxford, United Kingdom
Engaging citizen partners within a rapid review process
Maureen Dobbins | McMaster University, Canada
When seemingly essential methods don’t hold up in a pandemic: an adaptive approach to a living, rapid review on the SARS-CoV-2 antibody response
Haley Holmer | Portland VA Research Foundation, USA
Plenary session 2 (11.15 – 13.00)
The academic world quickly responded to the global pandemic and produced a staggering amount of research publications. Whilst nobody would disagree that we need organized collaborative research efforts in response to emerging healthcare needs, the reality is that large swathes of research on Covid-19 are of poor quality, which often mirrors the quality of bio-medical research in general. Our EBP champions will help us understand why there are too many publications and too little evidence, moving the focus from research methods to real-world evidence and highlighting how teaching EBP can help increase health research value.
KEYNOTE | Too many publications, too little evidence: what can editors of biomedical journals do?
Kamran Abbasi | The BMJ, United Kingdom
KEYNOTE | Real-world Evidence: another tool in the toolbox
John Concato | U.S. Food and Drug Administration, USA
The U.S. 21st Century Cures Act required the Food and Drug Administration (FDA) to evaluate the use of real-world evidence (RWE) to help support a) approval of a new indication for an already approved drug or b) post-approval requirements. This presentation will provide an overview of the RWE Program for drug and biologic development, coordinated by FDA’s Center for Drug Evaluation and Research.
Thirty years of developments in Evidence-Based Practice: have teaching and assessment methods in the health professions kept up?
Aliki Thomas | McGill University, Canada
A learning system using routinely collected cohort data to combine research and care for continuous evaluation of personalized treatment strategies: the MultiSCRIPT project
Perrine Janiaud | Univeristy Hospital Basel, Switzerland
Increasing value of health research by making evidence-based funding decision
Jong-wook Ban | Western Norway University of Applied Sciences, USA
See one, do one, teach one - Building capacity of african teachers of evidence-based health care through experiential learning
Anke Rohwer | Stellenbosch University, South Africa
Vaccine communication training for healthcare providers - an IMMUNION initiative
Aurélie De Waele | University of Antwerp, Belgium
Parallel session A (14.30 – 16.30)
How healthcare systems and the research interacted with patients and caregivers has changed over the course of the COVID-19 pandemic?Patients and caregiversengagement in care planning is a key factor forperson-centered care and quality of healthcare. It is relevant that the same level of engagement is ensured in evidence generation. In this session, worldwide researchers will introduce us to strategies and solutions to improve the quality of care and research by favoring patientsand caregiversengagement.
Peer feedback activity over critical appraisal of a RCT in a postgraduate-level online unit of study in introductory clinical epidemiology
Naomi Noguchi | University of Sydney, Australia
Invited to dinner but not to the table: web content accessibility evaluation for persons with disabilities
Patrick Okwen | Effective Basic Services (eBASE) Africa, Cameroon
Applying the behaviour change wheel to patient safety events to enhance Evidence-Based Practice in a pediatric tertiary care centre
Mari Somerville | IWK Health, Canada
The problem of citation bias – a scoping review
Hans Lund | Bergen University College, Norway
Characterising community hospitals vocations and quality of care delivered to generate evidence for informed decision-making
Chiara Reno | Università di Bologna, Italy
Impact of pragmatic trial design features on treatment effect estimates: the PragMeta project
Lars Hemkens | Univeristy Hospital Basel, Switzerland
Vitamin D for prevention and treatment of COVID-19. Transformation of a rapid review in a living systematic review
Rebeca Isabel-gomez | Fundación Progreso y Salud, Spain
Why is UK emergency care in crisis? Scoping analysis of routine population data
Nicholas Steel | University of East Anglia, United Kingdom
Using consumer surveys to impact the scope of clinical practice guidelines
Sandra Kaplan | Rutgers University, USA
Parallel session B (14.30 – 16.30)
Consumer perspectives of guidelines implementation: review of consumer contributions to guidelines for malaria
Pauline Ebaisong Akonjang | Effective Basic Services (eBASE) Africa, Cameroon
Perceived value and self-reported implementation of teaching Evidence-Based Dentistry (EBD) in indonesian dental schools: a national survey
Dani Firman | Universitas Padjadjaran, Indonesia
Medsyntax: a new, free and open source tool for improved literature research
Margot Verleg-gremmen | Martini Ziekenhuis Groningen, The Netherlands
Using the Master Adaptive Learning model to develop curriculum that enhances Evidenced-Based Practice
Drew M Keister | University of South Florida Morsani College of Medicine, USA
Evidence-based decision-making - development and piloting of an online training for nurses
Birte Berger-höger | University of Bremen, Germany
Evidence-Based Practice and knowledge translation: in tandem or in tension?
André Bussieres | Université du Québec a Trois Rivicres, Canada
Teaching EBM in general practice in the Netherlands; the power of a national network
Marie-louise Bartelink | UMC Utrecht, The Netherlands
Methods to improve digital literacy of health professionals to rapidly translate evidence into clinical practice
Christine East | La Trobe University, Australia
A qualitative study of students’ and teachers’ experiences with an online course in Evidence-Based Practice
Nina Rydland Olsen | Western Norway University of Applied Sciences, Norway
Plenary session 3 (08.30 – 10.45)
The global pandemic has clearly emphasized the need for rapid production of evidence to inform clinical decision-making and help give clinicians urgent answers. In this context, researchers have tried to improve the use of forms of knowledge synthesis that produce evidence in a resource-efficient manner. Our EBHC champions will trace the way to the future of evidence syntheses, outlining new methods and potential barriers for rapid and living syntheses.
KEYNOTE | Evolution and revolution: the future of evidence synthesis in Cochrane
Karla Soares-Weiser | Cochrane, United Kingdom
This keynote address highlights Cochrane's pivotal role in shaping the future of health and care through transformative shifts in evidence synthesis. We explore the evolution of systematic reviews, Cochrane's revolutionary changes, and the profound impact of the COVID-19 pandemic. With an ongoing structural transformation, Cochrane aligns its commitment to the United Nations Sustainable Development Goals, ensuring evidence synthesis contributes to improved health outcomes, equity, diversity, and inclusion. Looking forward, Cochrane's visionary approach prioritizes relevant evidence synthesis to inform decisions in health and care on a global scale.
KEYNOTE | Quenching the thirst for access to living practice guidelines
Holger Schünemann | McMaster University, Canada
Processes and methods for developing guidance in the setting of COVID-19: an international, cross-sectional study
Susan Norris | Oregon Health & Science University, USA
Learning on the job: using artificial intelligence and natural language processing to support rapid review methods
Kristine Read | McMaster University, Canada
A voice enabled point of care clinical search engine & clinical question capturing platform for Evidence-Based Medicine
Izhar Hasan | Rutgers University, USA
The impact of Evidence-Based Practice guidelines adherence on clinical outcomes in patients with cancer: a systematic review and meta-analysis
Ismaila Nofisat | McMaster University, Canada
Innovative methods for living and rapid evidence-informed clinical advice during the COVID-19 pandemic
Jennifer Yost | The American College of Physicians, USA
Plenary session 4 (11.15 – 13.00)
The global pandemic has highlighted the need for healthcare that is evidence-informed, sustainable, and that tackles inequities.
To this end, it is essential that health professionals are adequately trained in EBHC to change knowledge, attitudes and skills that could represent potential barriers to evidence-informed healthcare. In this plenary session, EBHC leaders will introduce us to potential barriers and solutions to improve health literacy and healthcare quality.
KEYNOTE | Tackling inequities and promoting a worldwide evidence-informed healthcare
Eleanor Ochodo | Kenya Medical Research Institute, Kenya
Health inequities are described as unfair or systematic differences in health. This presentation will discuss strategies in evidence-informed health care that have been brought forward to tackle health inequities, highlighting the progress and gaps that still need to be addressed.
KEYNOTE | Building a sustainable ecosystem of evidence: new challenges after the pandemic
Nino Cartabellotta | GIMBE Foundation, Italy
Updating Evidence Informed Healthcare (EIHC) tutorials using an anti-oppressive and diversity lens
Diana and Martin Dawes | University of British Columbia, Canada
Teaching Evidence-Based Medicine to large classes of undergraduate medical students: team-based learning versus small group discussionsl, a randomized controlled trial
Mona Nabulsi | American University of Beirut, Lebanon
Perception and attitude towards EBM in the GP specialty training in the Netherlands: an explorative qualitative study
Susanne Claessen | Amsterdam UMC, The Netherlands
Effectiveness of educational interventions for improving information literacy in healthcare professionals: a systematic review
Mauricette Lee | Lee Kong Chian School of Medicine, Singapore
Knowledge, attitudes, confidence, and behavior related to Evidence-Based Practice among healthcare professionals working in primary healthcare in Norway. Results from a cross-sectional survey
Nils Gunnar Landsverk | Oslo Metropolitan University, Norway
Parallel session C (14.30 – 16.30)
It is evident how much the pandemic has allowed new training and healthcare methods to be implemented. To date, digital technology is strongly present in healthcare and in the training of young professionals. In this session, worldwide researchers will show us how the use of digital technology can favor digital health interventions and support the learning health system, focusing on the challenges that the pandemic has highlighted in teaching EBHC.
The learning curve of bachelor nurses in a four day Evidence Based Practice course
Jessica Cramer-kruit | Martini Hospital, The Netherlands
Similar responsiveness of health-related quality of life outcome in patients with breast cancer undergoing systemic therapy
Juhl Carsten | University of Southern Denmark, Denmark
A bibliometric analysis of statistical terms used in American Physical Therapy Association journals: pre- and post- COVID lockdown
Clarisa Martinez | University of Southern California, USA
Growth and quality of evidence for evaluating digital health interventions: an assessment of registered clinical trials
Fujian Song | University of East Anglia, United Kingdom
Making decision trees from guidelines
Mirthe Tilma | the Netherlands Comprehensive Cancer Organisation, The Netherlands
International collaboration to increase efficiency of updating evidence syntheses to support guidelines for disease prevention
Julian Little | University of Ottawa, Canada
Creating infrastructure to support a learning health system with rapid, high-quality evidence
Bronwyn Southwell | University of Minnesota, USA
Efficacy of an online training programme to support the application of the guideline evidence-based health information: a randomised controlled trial and process evaluation
Julia Luhnen | Martin Luther University Halle-Wittenberg, Germany
A protocol for the practical application of human rights in World Health Organization guideline development
Rebecca Thomas | The University of Liverpool, United Kingdom
Teaching Evidence-Based Medicine to medical students using a Virtual Journal Club: a mixed method study
Paulo Pinho | MD ACCESS, LLC, Princeton, NJ, USA
Baseline imbalances in alirocumab and evolocumab trials: A meta-epidemiological study
Hendrika Luijendijk | University Medical Centre Groningen, The Netherlands
Parallel session D (14.30 – 16.30)
Experiences with integrating best evidence in clinical care in middle Africa through EBM Africa network
Meriam Ongolo | Effective Basic Services (eBASE) Africa, Cameroon
Teaching overdiagnosis to medical students and family physicians within an Evidence-Based Medicine framework
Eddy Lang | University of Calgary, Canada
Opportunities and challenges in communicating evidence to nurse leaders: experiences of online courses in Finland and China
Maritta Välimäki | University of Turku, Finland
EBM teaching in a pandemic: a pre-post comparison of medical students' self-efficacy for dealing with scientific literature
Maria Noftz | University of Luebeck, Germany
Developing a web-based evidence-based research training school – challenges and considerations
Hrund Thorsteinsson | University of Iceland, Iceland
Re-designing long-term care policy from a systems thinking perspective in the post-pandemic era
Peter Tsasis | York University, Canada
Implementation and evaluation of a new quality and patient safety module component across ten postgraduate nursing programmes: case study from the irish context
Aoife De Brun | University College Dublin, Ireland
Evidence-Based Practice education and programmatic assessment
Joan Verhoef | Rotterdam University of Applied Sciences, The Netherlands
The doctorate of physical therapy EBP curricular guidelines: uptake and challenges
Hilary Greenberger | Ithaca College, USA
Plenary session 5 (09.00 – 12.00)
Effective responses to public health emergencies should rely on translating rapidly emerging research into timely, evidence-informed policy and practice. This becomes even more important in disadvantaged countries where access to health care is not always guaranteed.We will learn from our EBHC experts how to improve the evidence translation and patients’ involvement in healthcare decisions, also focusing on the impact that technology could have on that.
KEYNOTE | How to improve patients' and consumers' involvement in healthcare decisions
Hilda Bastian | Cartoons and blogs at PLOS, and writes for The Atlantic, Australia
Are there individual, policy, or environmental changes that can make a major difference, or do we have to chip away at all of it while society shifts slowly towards better involvement in decision-making? What barriers to progress could we tackle? Hilda will draw on evidence and experience to identify potentially worthwhile actions for change.
KEYNOTE | AI evidence for use in clinical practice
Per Olav Vandvik | University of Oslo, Norway
The exponential increase in the number of machine learning or deep learning models, under the umbrella of artificial intelligence (AI), along with the unprecedented hype from the industry and their end-users necessitates careful reconsideration of evidence-based medicine principles for use of AI to inform policy and practice. In this talk, Dr.Vandvik will (on behalf of Farid Foroutan, new MAGIC sheriff in town for AI evidence) explain what AI means from a clinical practice perspective. He will exemplify both the potential and pitfalls of AI to increase value and reduce waste in the evidence ecosystem. Patient stories will demonstrate the importance for critically appraising the utility of AI tools on patient important outcomes, before applying these to care for patients.
The impact of Evidence-Based Practice on daily nursing and allied health practice
Henriette Smid-nanninga | Martini Hospital, The Netherlands
Adapting evidence-based peri-discharge complex interventions for reducing 30-day hospital readmissions among heart failure and COPD patients in Hong Kong
Vincent Chi Ho Chung | The Chinese University of Hong Kong, China
Responsive Evidence Systems for african policy needs
Marthe Bogne Penka | Effective Basic Services (eBASE) Africa, Cameroon
The effectiveness of an integrated knowledge translation intervention on the implementation of NEWS2 in nursing homes. A pragmatic cluster RCT
Thomas Potrebny | Western Norway University of Applied Sciences, Norway
Guideline implementation using the knowledge to action model: a mixed methods analysis of therapist performance triangulated with therapist and patient perspectives
Julie Tilson | University of Southern California, USA
Evidence to action: the role of issue briefs as a tool for discussion and NCD advocacy in five African countries
Nasreen Jessani | Stellenbosch University, South Africa
Impact of health library information resources on patient care: a cross-sectional survey of irish healthcare personnel
Brendan Leen | Health Service Executive, Ireland